RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 127 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,000 | -72.7% | 213 | -60.4% | 0.00% | -50.0% |
Q2 2021 | $11,000 | 0.0% | 538 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $11,000 | -50.0% | 538 | -27.0% | 0.00% | -60.0% |
Q4 2020 | $22,000 | +22.2% | 737 | -11.4% | 0.01% | 0.0% |
Q3 2020 | $18,000 | -5.3% | 832 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $19,000 | +46.2% | 832 | 0.0% | 0.01% | +20.0% |
Q1 2020 | $13,000 | -23.5% | 832 | +9.2% | 0.01% | +25.0% |
Q4 2019 | $17,000 | +1600.0% | 762 | +1365.4% | 0.00% | – |
Q3 2019 | $1,000 | -91.7% | 52 | -90.8% | 0.00% | -100.0% |
Q2 2019 | $12,000 | – | 563 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |